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Perforin deficiency in HIV pathogenesis 
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S-141 86 Huddinge, Sweden 
CD8 T cells play an important role in protection and 
control of HIV-l. Although HIV-1 infected individuals 
have a high frequency of HIV-l specific CD8 T cells, viral 
reservoirs persist and progressive immunodeficiency 
generally ensues in the absence of continuous potent 
anti-viral drugs. Maturation into competent cytotoxic 
CD45 RA+, CD27-, CD28- effector T lymphocytes is 
apparently blocked in HIV-l infected patients. Thus, 
both the acute and chronic phase of infection is asso- 
ciated with an increase in activated, partially immature 
CD8 T cells of memory phenotype. Circulating CD8 T 
cells in HIV-l infected subjects have an unusually high 
percentage of CD8 T cells containing cytolytic granule 
filled with granzymes A and B, but with low amounts of 
perforin. The combined release of granzyme and 
perforin is needed for induction of cytotoxic activity. 
Perforin is required for the intracellular uptake and 
intranuclear penetration of granzymes A and B where 
these proteins initiate the killing process. A disassoci- 
ation between extensive up-regulation of granzymes A 
and B, but significantly lower perforin induction in HIV 
specific CD8 T cells, is occurring already at acute onset 
of symptomatic primary HIV-l. This has been shown to 
be present through-out the course of the infection. In 
chronic phase, up to 80% of all HIV-specific CD8 T cells 
may express granzyme following in vitro antigen specific 
re-stimulation. However, only 1 to 5% of these cells 
express perforin. In vitro experiments clearly demon- 
strate that cytolytic granule-mediated exocytosis is a 
major killing pathway of HIV-l infected cells.Therefore, 
this in vivo abnormality may have clinical significance. 
Preliminary results indicate that long-term non- 
progressors have a higher incidence of HIV specific 
perforin expressing CD8 T cells as compared to patients 
with progressive disease. Assessments of EBV and CMV 
specific CD8 T cells demonstrate that virtually all effec- 
tor CTL co-express perforin and granzymes in granule. 
Nef has recently been shown to impair perforin 
expression in antigen specific CD8 T cells indicating that 
excessive Nef antigen load may be at least partially 
responsible for immune dysregulation. In addition, lack 
of HIV specific CD4 T cell help and insufficient co- 
stimulatory signalling by dendritic cells may further 
contribute to the immaturity and insufficient perforin 
expression of the CD8 T cells. These findings may have 
implications for immune reconstitution in HIV infected 
patients. 
Hyper-IgE and recurrent infection syndrome (Job’s 
syndrome): a rare disease with common problems 
Steven Holland 
National Znstitutes of Health, Besthesda, USA 
Hyper-IgE syndrome (HIES) is a rare autosomal dis- 
order characterized by recurrent infections, typically 
of the lower respiratory system and skin, eczema, 
extremely elevated levels of IgE, eosinophilia, and 
abnormalities of the connective tissue, skeleton, and 
dentition. The majority of patients have facial abnor- 
malities including ocular hypertelorism, a prominent, 
protruding, triangular mandible, and a broad, somewhat 
bulbous nose. Failure of primary dental deciduation, 
leading either to failure of secondary dentition eruption 
or retention of both sets of teeth is common Many 
patients also have abnormalities of bone formation and 
metabolism, which may result in fractures, severe 
scoliosis, kyphosis and short stature, and cranio- 
synostosis. HIES occurs spontaneously in all racial and 
ethnic groups, and in many cases is transmitted as an 
autosomal dominant trait. 
IgE is greatly elevated at some point in the life of 
patients with HIES. A few patients have been observed 
to drop their IgE levels below 2000 IU/ml as they get 
older and yet retain their high susceptibility to infection. 
Autosomal dominant transmission with variable 
penetrance is common. The rate of spontaneous 
occurrence is unknown, but sporadic cases account for 
at least half of those recognized so far. Genetic linkage 
to proximal 4q has been shown, but several families are 
not linked to 4q, suggesting that there are at least 2 
genetically distinct types of autosomal dominant HIES. 
There may also be autosomal recessive forms of HIES. 
Therefore, HIES is likely a complex autosomal disorder 
with both dominant and recessive forms. 
Patients usually present within the first days to months 
of life with severe eczema, mucocutaneous candidiasis, 
and severe diaper rash. Sinus or pulmonary infections, 
predominantly with S. aureus or Hemophilus infiuenzae, 
are common. Post-inflammatory pneumatoceles are often 
noted early in life. Otitis media and externa are common. 
Infections occur less frequently in bone and joints, and 
very infrequently in liver, kidneys, and the gastrointestinal 
tract. Documented sepsis is rare. Deep tissue infections 
are frequently extensions of cutaneous or dental 
infections such as paronychia or apical abscesses. 
Other pathogens that have been recovered include 
Aspergillus species, Pseudomonas aeruginosa, Strepto- 
coccus pneumoniae, group A streptococci, Cryptococcus 
neoformans, and C. albicans. Although several patients 
have survived into adulthood and middle age, there is 
often severe pulmonary destruction. Cerebrovascular 
events (strokes, reversible ischemic neurological deficits, 
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unidentified bright objects/T2 hyperintensities on MRI 
scanning, carotid artery aneurysms) have been seen in 
an unusually high number of patients. 
Frequent bony abnormalities are common in HIE. 
The frequency of pathologic fractures in the population 
reported by Grimbacher et al was 58%. Although the 
general mechanism for these abnormalities is unknown, 
Leung et al. have demonstrated increased in vitro bone 
resorption by monocytes from patients with HIE. 
The syndrome is defined by marked elevations of IgE 
(>2000 IU/ml), with levels of more than 50,000 IU/ml 
reported. White blood cell counts are typically in the 
normal range, but have been reported to range from 
60,000 to 1700 per microliter. Mild to moderate 
eosinophilia is the rule, although occasional patients 
do not show this. There is no correlation between IgE 
levels and degree of eosinophilia or clinical disease. 
Mucocutaneous candidiasis with involvement of mouth, 
vagina, intertriginous areas, fingernails, and toenails 
affects about 50% of patients with HIE. High-dose 
prolonged intravenous antibiotics are required for 
eradication of infection. Empirical acute coverage should 
consider S. aureus, H. in@enzae, and S. pneumoniae. 
The former two organisms account for the majority of 
acute infections. Colonization of pneumatoceles and 
bronchiectatic lung with Pseudomonas aeruginosa and 
Aspergillus species can be especially problematic. The 
role of prophylactic antibiotics has not been rigorously 
investigated in this setting but there is general consensus 
for their use. Most investigators direct coverage at S. 
aureus with a synthetic penicillin. 
A scoring system has been devised to aid in the formal 
diagnosis of HIE patients. 
Table 1. Findings in HIES 
Eczema 
Characteristic facies (>16y) 
Skin boils 
Pneumonias 
Mucocutaneous candidiasis 
Lung cysts 
Scoliosis (>16y) 
Delayed dental exfoliation 
Pathologic fractures 
Adapted from Grimbacher et al, 1999 
100% 
100% 
87% 
87% 
a3 96 
77% 
76% 
72% 
57% 
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Nonmyeloablative stem cell transplantation for 
malignant and nonmalignant hematopoietic disorders 
Ranier Storb 
Fred Hutchinson Cancer Research Center, Seattle, USA 
Conventional allogeneic hematopoietic stem cell trans- 
plantation (HSCT) relies on maximally tolerated doses 
of systemic chemoradiation both to eradicate cancer and 
to achieve host immunosuppression. The allografts then 
act to rescue patients from treatment-induced marrow 
aplasia and contribute graft-vs.-tumor effects of un- 
certain magnitude. Associated toxicities have limited 
treatment with HSCT to younger, medically fit patients 
with therapies administered on specialized hospital 
wards. 
This age restriction has excluded most patients with 
myeloid leukemias and B cell malignancies from trans- 
plantation. In an effort to address this limitation, we 
have developed a nonmyeloablative transplant approach 
in which the burden of tumor eradication has been 
shifted from cytotoxic agents to the graft-vs.-tumor 
effects. In studies using a large randombred canine 
model, we replaced the intense conditioning regimens 
customarily used for host immunosuppression in HSCT, 
and instead optimized immunosuppression with a 
combination of mycophenolate mofetil and cyclosporine 
given for a short period of time post transplantation. 
This served not only to control serious graft-versus-host 
disease (GVHD) but, as importantly, to reduce the 
magnitude of the host-versus-graft reaction. The clinical 
conditioning regimen currently used consists of only 
2 Gy of total body irradiation (TBI) and fludarabine. 
Preliminary clinical results in nearly 450 patients have 
shown the nonmyeloablative regimen used was safe and 
minimally toxic. The typical side effects of conventional 
HSCT such as alopecia, pancytopenia, and transfusion 
dependency were not encountered. Consequently, 57% 
of eligible patients were treated entirely as outpatients, 
with others having relatively short hospitalizations. 
The relatively short period of neutropenia has 
resulted in fewer bacteremias during the first 30 days 
after transplant compared to conventional transplant 
recipients (9% vs. 27%; p=O.Ol). Also, during the first 
100 days after transplant, high-risk nonmyeloablative 
transplant recipients had significantly less cytome- 
galovirus viremia and disease compared to conventional 
transplant recipients (p=O.Ol), though by 1 year after 
transplant the overall incidence of cytomegalovirus 
disease was comparable between the 2 groups. The 
onset of cytomegalovirus disease was significantly 
